ID   F261_HUMAN              Reviewed;         471 AA.
AC   P16118; B2RA88; B4DUN5; Q5JXS5; Q99951;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 3.
DT   28-JUN-2023, entry version 224.
DE   RecName: Full=6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 {ECO:0000305};
DE            Short=6PF-2-K/Fru-2,6-P2ase 1;
DE            Short=PFK/FBPase 1;
DE   AltName: Full=6PF-2-K/Fru-2,6-P2ase liver isozyme;
DE   Includes:
DE     RecName: Full=6-phosphofructo-2-kinase;
DE              EC=2.7.1.105 {ECO:0000250|UniProtKB:P07953};
DE   Includes:
DE     RecName: Full=Fructose-2,6-bisphosphatase;
DE              EC=3.1.3.46 {ECO:0000269|PubMed:2837207};
GN   Name=PFKFB1 {ECO:0000312|HGNC:HGNC:8872}; Synonyms=F6PK, PFRX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2163524; DOI=10.1093/nar/18.12.3652;
RA   Lange A.J., Pilkis S.J.;
RT   "Sequence of human liver 6-phosphofructo-2-kinase/fructose-2,6-
RT   bisphosphatase.";
RL   Nucleic Acids Res. 18:3652-3652(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 94-471, FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=2837207; DOI=10.1016/s0006-291x(88)81226-9;
RA   Algaier J., Uyeda K.;
RT   "Molecular cloning, sequence analysis, and expression of a human liver cDNA
RT   coding for fructose-6-P,2-kinase:fructose-2,6-bisphosphatase.";
RL   Biochem. Biophys. Res. Commun. 153:328-333(1988).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 40-471 IN COMPLEX WITH ATP ANALOG,
RP   AND SUBUNIT.
RX   PubMed=12379646; DOI=10.1074/jbc.m209105200;
RA   Lee Y.H., Li Y., Uyeda K., Hasemann C.A.;
RT   "Tissue-specific structure/function differentiation of the liver isoform of
RT   6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.";
RL   J. Biol. Chem. 278:523-530(2003).
CC   -!- FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate.
CC       {ECO:0000269|PubMed:2837207}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-fructose 2,6-bisphosphate + H2O = beta-D-fructose 6-
CC         phosphate + phosphate; Xref=Rhea:RHEA:17289, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57634, ChEBI:CHEBI:58579; EC=3.1.3.46;
CC         Evidence={ECO:0000269|PubMed:2837207};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17290;
CC         Evidence={ECO:0000250|UniProtKB:P07953};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + beta-D-fructose 6-phosphate = ADP + beta-D-fructose 2,6-
CC         bisphosphate + H(+); Xref=Rhea:RHEA:15653, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:57634, ChEBI:CHEBI:58579,
CC         ChEBI:CHEBI:456216; EC=2.7.1.105;
CC         Evidence={ECO:0000250|UniProtKB:P07953};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15654;
CC         Evidence={ECO:0000250|UniProtKB:P07953};
CC   -!- ACTIVITY REGULATION: Phosphorylation at Ser-33 inhibits the kinase and
CC       activates the bisphosphatase. {ECO:0000250|UniProtKB:P07953}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12379646}.
CC   -!- INTERACTION:
CC       P16118; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-709807, EBI-742054;
CC       P16118; P35557: GCK; NbExp=2; IntAct=EBI-709807, EBI-709928;
CC       P16118; Q9H079: KATNBL1; NbExp=5; IntAct=EBI-709807, EBI-715394;
CC       P16118; P27815-4: PDE4A; NbExp=3; IntAct=EBI-709807, EBI-12080840;
CC       P16118; P16118: PFKFB1; NbExp=7; IntAct=EBI-709807, EBI-709807;
CC       P16118; Q16875: PFKFB3; NbExp=3; IntAct=EBI-709807, EBI-764464;
CC       P16118; Q16877: PFKFB4; NbExp=5; IntAct=EBI-709807, EBI-764534;
CC       P16118; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-709807, EBI-949255;
CC       P16118; Q2TAL6: VWC2; NbExp=3; IntAct=EBI-709807, EBI-11957238;
CC       P16118; Q8N554: ZNF276; NbExp=3; IntAct=EBI-709807, EBI-750821;
CC       P16118; Q6S9Z5: ZNF474; NbExp=3; IntAct=EBI-709807, EBI-17269964;
CC       P16118; Q8N720: ZNF655; NbExp=3; IntAct=EBI-709807, EBI-625509;
CC       P16118; P0C7X2: ZNF688; NbExp=3; IntAct=EBI-709807, EBI-4395732;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P16118-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P16118-2; Sequence=VSP_054795;
CC   -!- TISSUE SPECIFICITY: Liver.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the phosphoglycerate
CC       mutase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X52638; CAA36861.1; -; mRNA.
DR   EMBL; AK314089; BAG36785.1; -; mRNA.
DR   EMBL; AK300724; BAG62397.1; -; mRNA.
DR   EMBL; AL049732; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL020991; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096079; AAH96079.1; -; mRNA.
DR   EMBL; M19938; AAA35818.1; -; mRNA.
DR   CCDS; CCDS14364.1; -. [P16118-1]
DR   CCDS; CCDS65273.1; -. [P16118-2]
DR   PIR; S12732; S12732.
DR   RefSeq; NP_001258733.1; NM_001271804.1.
DR   RefSeq; NP_001258734.1; NM_001271805.1. [P16118-2]
DR   RefSeq; NP_002616.2; NM_002625.3. [P16118-1]
DR   PDB; 1K6M; X-ray; 2.40 A; A/B=40-471.
DR   PDBsum; 1K6M; -.
DR   AlphaFoldDB; P16118; -.
DR   BMRB; P16118; -.
DR   SMR; P16118; -.
DR   BioGRID; 111228; 27.
DR   ComplexPortal; CPX-1992; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 complex.
DR   IntAct; P16118; 17.
DR   MINT; P16118; -.
DR   STRING; 9606.ENSP00000364145; -.
DR   BindingDB; P16118; -.
DR   ChEMBL; CHEMBL3421524; -.
DR   DrugBank; DB02930; Adenosine 5'-[gamma-thio]triphosphate.
DR   DrugBank; DB02393; D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate.
DR   DrugBank; DB04493; Fructose-6-phosphate.
DR   DrugBank; DB04137; Guanosine-5'-Triphosphate.
DR   DrugBank; DB13749; Magnesium gluconate.
DR   DrugBank; DB02515; sn-glycerol 3-phosphate.
DR   DEPOD; PFKFB1; -.
DR   GlyGen; P16118; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P16118; -.
DR   PhosphoSitePlus; P16118; -.
DR   BioMuta; PFKFB1; -.
DR   DMDM; 2507178; -.
DR   EPD; P16118; -.
DR   jPOST; P16118; -.
DR   MassIVE; P16118; -.
DR   PaxDb; P16118; -.
DR   PeptideAtlas; P16118; -.
DR   ProteomicsDB; 5200; -.
DR   ProteomicsDB; 53291; -. [P16118-1]
DR   Antibodypedia; 533; 284 antibodies from 28 providers.
DR   DNASU; 5207; -.
DR   Ensembl; ENST00000375006.8; ENSP00000364145.3; ENSG00000158571.11. [P16118-1]
DR   Ensembl; ENST00000545676.5; ENSP00000444074.1; ENSG00000158571.11. [P16118-2]
DR   GeneID; 5207; -.
DR   KEGG; hsa:5207; -.
DR   MANE-Select; ENST00000375006.8; ENSP00000364145.3; NM_002625.4; NP_002616.2.
DR   UCSC; uc004dty.3; human. [P16118-1]
DR   AGR; HGNC:8872; -.
DR   CTD; 5207; -.
DR   DisGeNET; 5207; -.
DR   GeneCards; PFKFB1; -.
DR   HGNC; HGNC:8872; PFKFB1.
DR   HPA; ENSG00000158571; Group enriched (adipose tissue, liver, skeletal muscle, tongue).
DR   MIM; 311790; gene.
DR   neXtProt; NX_P16118; -.
DR   OpenTargets; ENSG00000158571; -.
DR   PharmGKB; PA33211; -.
DR   VEuPathDB; HostDB:ENSG00000158571; -.
DR   eggNOG; KOG0234; Eukaryota.
DR   GeneTree; ENSGT00950000182835; -.
DR   HOGENOM; CLU_006383_1_1_1; -.
DR   InParanoid; P16118; -.
DR   OMA; CKMEMIK; -.
DR   OrthoDB; 2013830at2759; -.
DR   PhylomeDB; P16118; -.
DR   TreeFam; TF313541; -.
DR   BioCyc; MetaCyc:HS08310-MON; -.
DR   BRENDA; 2.7.1.105; 2681.
DR   BRENDA; 3.1.3.46; 2681.
DR   PathwayCommons; P16118; -.
DR   Reactome; R-HSA-163358; PKA-mediated phosphorylation of key metabolic factors.
DR   Reactome; R-HSA-163767; PP2A-mediated dephosphorylation of key metabolic factors.
DR   Reactome; R-HSA-9634600; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism.
DR   SABIO-RK; P16118; -.
DR   SignaLink; P16118; -.
DR   BioGRID-ORCS; 5207; 9 hits in 784 CRISPR screens.
DR   ChiTaRS; PFKFB1; human.
DR   EvolutionaryTrace; P16118; -.
DR   GenomeRNAi; 5207; -.
DR   Pharos; P16118; Tbio.
DR   PRO; PR:P16118; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P16118; protein.
DR   Bgee; ENSG00000158571; Expressed in hindlimb stylopod muscle and 105 other tissues.
DR   ExpressionAtlas; P16118; baseline and differential.
DR   Genevisible; P16118; HS.
DR   GO; GO:0043540; C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0003873; F:6-phosphofructo-2-kinase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0070095; F:fructose-6-phosphate binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.
DR   GO; GO:0019210; F:kinase inhibitor activity; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006000; P:fructose metabolic process; IEA:InterPro.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:UniProtKB.
DR   GO; GO:0006096; P:glycolytic process; TAS:UniProtKB.
DR   GO; GO:1904539; P:negative regulation of glycolytic process through fructose-6-phosphate; IEA:Ensembl.
DR   GO; GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0033762; P:response to glucagon; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 3.40.50.1240; Phosphoglycerate mutase-like; 1.
DR   InterPro; IPR003094; 6Pfruct_kin.
DR   InterPro; IPR013079; 6Phosfructo_kin.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001345; PG/BPGM_mutase_AS.
DR   PANTHER; PTHR10606; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; 1.
DR   PANTHER; PTHR10606:SF15; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1; 1.
DR   Pfam; PF01591; 6PF2K; 1.
DR   Pfam; PF00300; His_Phos_1; 1.
DR   PIRSF; PIRSF000709; 6PFK_2-Ptase; 1.
DR   PRINTS; PR00991; 6PFRUCTKNASE.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF53254; Phosphoglycerate mutase-like; 1.
DR   PROSITE; PS00175; PG_MUTASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Hydrolase;
KW   Kinase; Multifunctional enzyme; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   CHAIN           2..471
FT                   /note="6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
FT                   1"
FT                   /id="PRO_0000179960"
FT   REGION          2..250
FT                   /note="6-phosphofructo-2-kinase"
FT   REGION          251..471
FT                   /note="Fructose-2,6-bisphosphatase"
FT   ACT_SITE        131
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        161
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        259
FT                   /note="Tele-phosphohistidine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   ACT_SITE        328
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         49..57
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:12379646"
FT   BINDING         82
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         105
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         133
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         139
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         170..175
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:12379646"
FT   BINDING         175
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         196
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         200
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         258
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         265
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         271
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         308
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         339
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         350..353
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         353
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         357
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         368
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         394..398
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         394
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         398
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         430
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:12379646"
FT   SITE            393
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P00950"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   MOD_RES         33
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   VAR_SEQ         1..73
FT                   /note="MSPEMGELTQTRLQKIWIPHSSGSSRLQRRRGSSIPQFTNSPTMVIMVGLPA
FT                   RGKTYISTKLTRYLNWIGTPT -> MEEKTSRI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054795"
FT   CONFLICT        305
FT                   /note="H -> R (in Ref. 1; CAA36861)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359
FT                   /note="R -> H (in Ref. 5; AAA35818)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        397..398
FT                   /note="MR -> HA (in Ref. 5; AAA35818)"
FT                   /evidence="ECO:0000305"
FT   STRAND          43..48
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           55..68
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          73..77
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           78..83
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           91..94
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           99..121
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          126..132
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           137..150
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          153..160
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           164..175
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           187..201
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   TURN            209..214
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          217..221
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   TURN            222..225
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          226..230
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           235..244
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          254..258
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           263..266
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           278..293
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          300..303
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           307..314
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           332..334
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           339..345
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           347..355
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   TURN            357..359
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           368..384
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          386..392
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           394..405
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   TURN            409..411
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           412..414
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          421..427
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   STRAND          429..438
FT                   /evidence="ECO:0007829|PDB:1K6M"
FT   HELIX           460..464
FT                   /evidence="ECO:0007829|PDB:1K6M"
SQ   SEQUENCE   471 AA;  54681 MW;  C4FF081A295FB7D3 CRC64;
     MSPEMGELTQ TRLQKIWIPH SSGSSRLQRR RGSSIPQFTN SPTMVIMVGL PARGKTYIST
     KLTRYLNWIG TPTKVFNLGQ YRREAVSYKN YEFFLPDNME ALQIRKQCAL AALKDVHNYL
     SHEEGHVAVF DATNTTRERR SLILQFAKEH GYKVFFIESI CNDPGIIAEN IRQVKLGSPD
     YIDCDREKVL EDFLKRIECY EVNYQPLDEE LDSHLSYIKI FDVGTRYMVN RVQDHIQSRT
     VYYLMNIHVT PRSIYLCRHG ESELNIRGRI GGDSGLSVRG KQYAYALANF IQSQGISSLK
     VWTSHMKRTI QTAEALGVPY EQWKALNEID AGVCEEMTYE EIQEHYPEEF ALRDQDKYRY
     RYPKGESYED LVQRLEPVIM ELERQENVLV ICHQAVMRCL LAYFLDKSSD ELPYLKCPLH
     TVLKLTPVAY GCKVESIYLN VEAVNTHREK PENVDITREP EEALDTVPAH Y
//
